Myrtle S. Potter - 19 Aug 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John G. Saia, as attorney-in-fact for Myrtle S. Potter
Issuer symbol
GH
Transactions as of
19 Aug 2025
Net transactions value
-$1,535
Form type
4
Filing time
20 Aug 2025, 19:51:09 UTC
Previous filing
18 Aug 2025
Next filing
17 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
POTTER MYRTLE S Director 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Myrtle S. Potter 20 Aug 2025 0001214130

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Sale $1,535 -26 -0.14% $59.02 18,239 19 Aug 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).